Resultado da Busca
18 de fev. de 2021 · El adenocarcinoma in situ (AIS) El adenocarcinoma de tipo endocervical-tipo adenocarcinoma es el más común (70% de los adenocarcinomas) y puede estar precedido por un adenocarcinoma in situ (AIS), también conocido como neoplasia intraepitelial glandular cervical (CGIN), que es un conocido precursor del adenocarcinoma (Ostör et al. 2000).
22 de abr. de 2014 · Cervical adenocarcinoma in situ occurs in the glandular tissue of the cervix and is the condition which leads to invasive adenocarcinoma 1. The average age of women who are diagnosed with cervical adenocarcinoma in situ (AIS) is 36.9 2. Sadly, in most areas with well-established cervical screening programs, there has been no obvious reduction ...
17 de mar. de 2021 · Adenocarcinoma in situ (AIS) is an HPV-associated precancerous lesion of the glandular cells of the endocervix and the precursor to endocervical adenocarcinoma. Initial Management. If AIS is identified on a colposcopic biopsy, in the absence of a visible mass concerning for invasive cancer, the next step is a diagnostic excisional procedure.
27 de fev. de 2024 · Carcinoma in situ, or stage 0 cancer, refers to precancerous cells in a limited area. It is not cancer and may not become malignant. Learn more.
2 de nov. de 2021 · Reproducibility of the distinction between invasive and in situ adenocarcinoma is poor and distinction cannot be made in up to 20% of cases (Mod Pathol 2016;29:879, Int J Gynecol Pathol 2000;19:29) Endometrial endometrioid adenocarcinoma: No in situ cervical adenocarcinoma Continuity between cervix and endometrial tumors
24 de abr. de 2018 · The standard treatment for cervical adenocarcinoma in situ (AIS) is hysterectomy, which is a more aggressive treatment than that used for squamous intraepithelial lesions. Several previous studies have primarily demonstrated that the loop electrosurgical excision procedure (LEEP) is as safe and effective as cold knife cone (CKC) biopsy when AIS is unexpectedly found in a loop excision.
The concept of adenocarcinoma in situ (AIS) was first proposed in 1953 by Friedell and McKay on the basis of two cases of cervical adenocarcinoma that also appeared to contain a noninvasive precursor lesion. 1 However, in the ensuing decades, despite remarkable progress in the understanding of the development of cervical squamous carcinoma, AIS remained obscure.
